January 2024 - Page 16 of 272

NASDAQ Companies - January 31, 2024

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the […]

NASDAQ Companies - January 31, 2024

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has […]

NASDAQ Companies - January 31, 2024

Nasdaq Announces Quarterly Dividend of $0.22 Per Share

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a […]

NASDAQ Companies - January 31, 2024

SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

STAMFORD, Conn., Jan. 31, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe […]

NASDAQ Companies - January 31, 2024

Sound Group Inc. Issues Letter to Shareholders

SINGAPORE, Jan. 31, 2024 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global audio-centric […]

NASDAQ Companies - January 31, 2024

Tilray Beers: A Lock for the Big Game

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) — As football fans gear up for the biggest showdown of the year, […]

NASDAQ Companies - January 31, 2024

Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and […]